IS7012A - Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum - Google Patents

Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Info

Publication number
IS7012A
IS7012A IS7012A IS7012A IS7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A IS 7012 A IS7012 A IS 7012A
Authority
IS
Iceland
Prior art keywords
cocaine
obstructive
adenosine
disease
mixture
Prior art date
Application number
IS7012A
Other languages
English (en)
Inventor
A. Armstrong Roisin
Yeadon Michael
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0129275A external-priority patent/GB0129275D0/en
Priority claimed from GB0129396A external-priority patent/GB0129396D0/en
Priority claimed from GB0210240A external-priority patent/GB0210240D0/en
Priority claimed from GB0210238A external-priority patent/GB0210238D0/en
Priority claimed from PCT/EP2002/005725 external-priority patent/WO2002096462A1/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS7012A publication Critical patent/IS7012A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
IS7012A 2001-05-25 2003-10-31 Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum IS7012A (is)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US29360601P 2001-05-25 2001-05-25
US29384201P 2001-05-25 2001-05-25
GB0129275A GB0129275D0 (en) 2001-12-06 2001-12-06 Pharmaceutical combination
GB0129396A GB0129396D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
GB0210240A GB0210240D0 (en) 2002-05-03 2002-05-03 Pharmaceutical combination
GB0210238A GB0210238D0 (en) 2002-05-03 2002-05-03 Pharmaceutical composition
PCT/EP2002/005725 WO2002096462A1 (en) 2001-05-25 2002-05-24 An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases

Publications (1)

Publication Number Publication Date
IS7012A true IS7012A (is) 2003-10-31

Family

ID=37667302

Family Applications (2)

Application Number Title Priority Date Filing Date
IS7012A IS7012A (is) 2001-05-25 2003-10-31 Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum
IS7015A IS7015A (is) 2001-05-25 2003-10-31 PDE 4 hindri og and-kólínergur miðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Family Applications After (1)

Application Number Title Priority Date Filing Date
IS7015A IS7015A (is) 2001-05-25 2003-10-31 PDE 4 hindri og and-kólínergur miðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum

Country Status (1)

Country Link
IS (2) IS7012A (is)

Also Published As

Publication number Publication date
IS7015A (is) 2003-10-31

Similar Documents

Publication Publication Date Title
EE200300586A (et) Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks
AU2003273300A8 (en) Modified glp-1 receptor agonists and their pharmacological methods of use
PT1189916E (pt) N-pirazole agonistas do receptor a2a
NO20025488D0 (no) Stabiliserte tetrasoliumreagenssammensetninger og fremgangsmÕter for deres anvendelse
NO20025489L (no) Stabiliserte tetrasolium-fenasin-reagens-sammensetninger og fremgangsmåterfor deres anvendelse
IL164759A0 (en) Use of tnfalpha antibodies and another drug
IL160706A0 (en) Peptides acting as both glp-1 receptor agonists and their pharmacological methods of use
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
ATE453647T1 (de) Adenosin a2a rezeptor antagonisten
IL163743A0 (en) Haloacetamide and azide substituted compounds and methods of use thereof
IL161572A0 (en) Adenosine a2a receptor antagonists
GB0107822D0 (en) Sapogenin derivatives their synthesis and use methods based upon their use
IL156992A0 (en) Novel receptors for helicobacter pylori and use thereof
NO20042692L (no) Sementakselerator og fremgangsmate
DK1556382T3 (da) 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
IS2487B (is) Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á
AU2002351175A8 (en) Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
AU2003268075A8 (en) Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents
IS7012A (is) Adenósín A2A viðtaka gerandefni og and-kólínergurmiðill í blöndu til meðhöndlunar á teppandi kokrennusjúkdómum
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
HUP0402299A3 (en) Anti-influenza drugs containing ambroxol and bromhexine and process for its preparation
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
PL370739A1 (en) Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists